Pages that link to "Q48409681"

The following pages link to Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice (Q48409681):

Displaying 27 items.

• Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea (Q28115635) (← links)
• Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution (Q28581795) (← links)
• Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice (Q30558687) (← links)
• Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice (Q33688727) (← links)
• Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance (Q33924266) (← links)
• Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration (Q34110890) (← links)
• Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter (Q34150552) (← links)
• Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. (Q34218993) (← links)
• Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments (Q34273564) (← links)
• Defective presynaptic choline transport underlies hereditary motor neuropathy. (Q34310899) (← links)
• Motor neuron-specific overexpression of the presynaptic choline transporter: impact on motor endurance and evoked muscle activity (Q34355414) (← links)
• Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice (Q34586508) (← links)
• Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. (Q35187232) (← links)
• Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics. (Q35589042) (← links)
• Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats (Q35951552) (← links)
• Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter (Q36306913) (← links)
• Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice (Q36486037) (← links)
• Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems (Q36901254) (← links)
• The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention (Q37012325) (← links)
• Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression (Q37161065) (← links)
• Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits (Q37397067) (← links)
• Cholinergic genetics of visual attention: Human and mouse choline transporter capacity variants influence distractibility (Q38893910) (← links)
• Ubiquitin C-terminal hydrolase L1 interacts with choline transporter in cholinergic cells (Q39024141) (← links)
• Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotine (Q40044945) (← links)
• Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine (Q41865432) (← links)
• B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments (Q42121818) (← links)
• Genomic variants in an inbred mouse model predict mania-like behaviors. (Q55000058) (← links)